AN OVERVIEW OF ANTI-TUBERCULOSIS TREATMENT (ATT) IN CAT I NEWLY DIAGNOSED CASES OF TUBERCULOSIS IN RNTCP.

Corresponding Author:
Dr. Ratan Kumar,
Department of Pulmonary Medicine,
LN Medical College, Bhopal,
Madhya Pradesh, India.
E-mail: ratan_vaish@yahoo.co.in

ABSTRACT

BACKGROUND

Tuberculosis (TB) remains a global public health problem and a major cause of death from a single infectious agent among adults in India and other developing countries. The aim of this study is to characterise effectiveness and outcome of antituberculosis treatment among newly diagnosed patients in RNTCP.

Materials and methods

This is a retrospective descriptive study of a newly diagnosed TB patients of all age groups attending OPD of various departments of LN Medical College and JK Hospital, Bhopal, M. P. (India) between a period of January 2012 and September 2015.

ResultS

A total of 360 patients were found eligible for this study, who were diagnosed and received ATT under DOTS in RNTCP. In different age groups percentage of patients observed were 14.72%, 65.28% and 20.00% in 0 - 14 years, 15 - 45 years and above 45 years respectively.

Conclusion

Maximum patients 65.28% (235) were registered in the age group of 15 – 45 years. Overall, treatment outcome were observed as follows- 86.39% treatment successful, 6.11% defaulted, 2.78% failed and 4.17% died. Higher percentage of treatment successful (98.11%) was observed in the age group of 0 - 14 years, whereas higher percentage of both defaulter (12.50%) and mortality (15.28%) with lower treatment successful rate (68.06%) were observed in the age group of above 45 years. Higher percentage of defaulter, failure and mortality were observed in males and PTB patients in comparison to females and EPTB. Overall, significant weight gain (92.60%) with treatment being successful (86.39%) were observed in this study.

Keywords

ATT, Newly diagnosed TB, DOTS, RNTCP.